A consultation is now underway on the review/development of the following share-care guidelines, with drafts being circulated to the HSCNI network for comment.
Cinacalcet (includes renal indication)
Liothyronine (NEW shared-care guideline)
Somatropin (Growth Hormone)
Please click on the link below to find out more or for contact details if you wish to take part in the consultation.